EMA concludes review of weight management medicine Mysimba (naltrexone / bupropion) – Currax Pharmaceuticals
EMA’s human medicines committee (CHMP) has finalised its review of Mysimba (naltrexone / bupropion), a medicine used for weight management in adults with obesity or overweight. The review… read more.
